Sutton Nicole J, Greenberg Mark A, Menegus Mark A, Lui George, Pass Robert H
Division of Cardiology, Department of Pediatrics, Children's Hospital at Montefiore, Bronx, NY 10467, USA.
Congenit Heart Dis. 2013 Mar-Apr;8(2):111-6. doi: 10.1111/chd.12004. Epub 2012 Sep 25.
The purpose of this study is to describe the outcomes of cardiac catheterizations performed by pediatric interventional cardiologists in an adult catheterization laboratory on adult patients with congenital heart disease (CHD).
With improved survival rates, the number of adults with CHD increases by ∼5%/year; this population often requires cardiac catheterization.
From January 2005 to December 2009, two groups of patients were identified, an adult group (>21 years) and an adolescent group (13-21 years), who had catheterizations performed by pediatric interventional staff.
Fifty-seven catheterizations were performed in 53 adults, while 59 were performed in 47 adolescents. The male to female ratio differed significantly between groups; only 15/53 (28%) of adults were male vs. 26/47 (55%) of adolescents (P =.006). Among adults, 27 had previously corrected CHD, 16 with atrial septal defect (ASD), and six with patent foramen ovale (PFO). This differed significantly from the adolescents, where only 30 had previously corrected CHD, seven with ASD, and one with PFO (P =.012). Among adults who were catheterized, interventions were performed on 28/53 (53%). All interventions were successful and included ASD/PFO closure, patent ductus arteriosus occlusion, coarctation dilation, pulmonary artery dilations, and one saphenous vein graft aneurysm closure. Nineteen adults had coronary angiography performed by adult interventionalists in consult with pediatric interventionalists. Two complications occurred among adults (3.8%) vs. one complication (2%; P = 1) among adolescents. No femoral vessel complications or catheterization-associated mortality occurred.
Cardiac catheterizations can be performed effectively and safely in adults with CHD by pediatric interventional cardiologists in an adult catheterization laboratory.
本研究旨在描述儿科介入心脏病专家在成人导管实验室为患有先天性心脏病(CHD)的成年患者进行心导管插入术的结果。
随着生存率的提高,成年CHD患者数量每年增加约5%;这一人群常常需要进行心导管插入术。
2005年1月至2009年12月,确定了两组患者,成年组(>21岁)和青少年组(13 - 21岁),他们接受了儿科介入人员进行的导管插入术。
53名成年人接受了57次导管插入术,而47名青少年接受了59次。两组的男女比例差异显著;成年人中只有15/53(28%)为男性,而青少年中为26/47(55%)(P = 0.006)。在成年人中,27人曾接受过CHD矫正,16人患有房间隔缺损(ASD),6人患有卵圆孔未闭(PFO)。这与青少年有显著差异,青少年中只有30人曾接受过CHD矫正,7人患有ASD,1人患有PFO(P = 0.012)。在接受导管插入术的成年人中,28/53(53%)进行了干预。所有干预均成功,包括ASD/PFO封堵、动脉导管未闭封堵、缩窄扩张、肺动脉扩张以及1例大隐静脉移植瘤封堵。19名成年人由成人介入专家在与儿科介入专家会诊后进行了冠状动脉造影。成年人中发生了2例并发症(3.8%),青少年中发生了1例并发症(2%;P = 1)。未发生股血管并发症或与导管插入术相关的死亡。
儿科介入心脏病专家在成人导管实验室可为成年CHD患者有效且安全地进行心导管插入术。